SMU-CX1
SMU-CX1 is a specific TLR3 inhibitor (IC50: 0.11 μM) with IC50 ranging from 0.14-0.33 μM against multiple influenza A virus subtypes. SMU-CX1 inhibits the viral PB2 and NP proteins with an IC50 of 0.43 μM for SARS-CoV-2 activity. SMU-CX1 also inhibits inflammatory factors in host cells, including IFN-β, IP-10, and CCL-5[1].
Product Specifications
CAS Number
10371-86-5
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
SARS-CoV; Toll-like Receptor (TLR)
Type
Natural Products
Related Pathways
Anti-infection; Immunology/Inflammation
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/smu-cx1.html
Purity
99.9
Solubility
10 mM in DMSO
Smiles
COC1=CC=C2C(C(C(C)=C3C(C=CN=C3)=C4C)=C4N2)=C1
Molecular Formula
C18H16N2O
Molecular Weight
276.33
Precautions
H302, H315, H319, H335
References & Citations
[1]Pan Y, et al. Discovery of an ellipticine derivative as TLR3 inhibitor against influenza A virus and SARS-CoV-2. Bioorg Med Chem Lett. 2024 Mar 15;101:129672.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Natural Products
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL312735V 500 µL Each
GMF beta (GMFB) Human shRNA Lentiviral Particle (Locus ID 2764)
Sign In for Pricing
View Details MBS7095626 Inquire
Recombinant Scotophilus heathi Cytochrome b (MT-CYB), partial
Sign In for Pricing
View Details 
HP234547 200 Reactions
C1orf185 Human qPCR Primer Pair (NM_001136508)
Sign In for Pricing
View Details